Human RECQ helicases: Roles in DNA metabolism, mutagenesis and cancer biology

Seminars in Cancer Biology

Volumn 20, Issue 5, 2010, Pages 329-339

  Monnat Jr , Raymond J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bloom syndrome; Cancer chemotherapy; Cancer predisposition syndrome; DNA repair; DNA replication; Genetic instability; Homologous recombination; Premature aging syndrome; RECQ helicases; Rothmund Thomson syndrome; Telomeres; Werner syndrome

Indexed keywords

RECQ HELICASE;

BLOOM SYNDROME; CANCER SUSCEPTIBILITY; DNA DAMAGE; DNA METABOLISM; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; GENE DELETION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HYDROLYSIS; MISSENSE MUTATION; MUTAGENESIS; NUCLEIC ACID METABOLISM; PREMATURE AGING; REVIEW; ROTHMUND THOMSON SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; SISTER CHROMATID EXCHANGE; SOMATIC MUTATION; TELOMERE; WERNER SYNDROME;

BLOOM SYNDROME; DNA; DNA REPAIR; DNA REPLICATION; GENOMIC INSTABILITY; HUMANS; MUTAGENESIS; MUTATION; NEOPLASMS; RECQ HELICASES; ROTHMUND-THOMSON SYNDROME; TELOMERE; WERNER SYNDROME;

EID: 78649467087     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.10.002     Document Type: Review

References (128)

1. Singleton M.R., Dillingham M.S., Wigley D.B. Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem 2007, 76(1):23-50.
2. Vindigni A., Marino F., Gileadi O. Probing the structural basis of RecQ helicase function. Biophys Chem 2010, 149:67-77.
3. Bloom D. Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs. Am J Dis Child 1954, 88:754-758.
4. German J. Bloom syndrome: a Mendelian prototype of somatic mutational disease. Medicine 1993, 72:393-406.
5. German J. Bloom's syndrome. VIII. Review of clinical and genetic aspects. Genetic diseases among Askenazi jews 1979, 121-139. Raven Press, New York. R.M. Goodman, A.G. Motulsky (Eds.).
6. German J. Bloom's syndrome: XX. The first 100 cancers. Cytogenet Cell Genet 1997, 93:100-106.
7. Epstein C.J., Martin G.M., Schultz A.L., Motulsky A.G. Werner's syndrome: a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 1966, 45:177-221.
8. Goto M. Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 1997, 98:239-254.
9. Monnat R.J. Werner syndrome as a model of human aging. Handbook of models for human aging 2006, 961-976. Elsevier Academic Press, Amsterdam. P.M. Conn (Ed.).
10. Werner O. On cataract in conjunction with scleroderma [Hoehn H, Trans.]. In: Salk D, Fujiwara Y, Martin GM, editors. Werner's syndrome and human aging. New York: Plenum Press; 1985. pp. 1-14.
11. Tollefsbol T.O., Cohen H.J. Werner's sydrome: an underdiagnosed disorder resembling premature aging. Age 1984, 7:75-88.
12. Goto M., Miller R.W., Ishikawa Y., Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 1996, 5:239-246.
13. Monnat R.J. Cancer pathogenesis in the human RecQ helicase deficiency syndromes. From premature gray hair to helicase - Werner syndrome: implications for aging and cancer 2001, 83-94. Japan Scientific Societies Press, Tokyo, Japan. M. Goto, R.W. Miller (Eds.).
14. Monnat R.J. Werner syndrome. WHO/IARC Monograph on Pathology and Genetics of Tumours of Soft Tissue and Bone 2002, 273-274. Lyon. FletcherC, K. Unni, F. Mertens (Eds.).
15. Huang S., Lee L., Hanson N.B., et al. The spectrum of WRN mutations in Werner syndrome patients. Human Mutat 2006, 27:558-567.
16. Rothmund A. Ueber cataracten in verbindung mit einer eigentümlichen hautdegenera-tion. Arch Klin Exp Ophtal 1868, 14(1):159-182.
17. Thomson M.S. Poikiloderma congenitale. Br J Dermatol 1936, 48:221-234.
18. Taylor W.B. Rothmund's syndrome-Thomson's syndrome: congenital poikiloderma with and without juvenile cataracts. A review of the literature, report of a case, and discussion of the relationship of the two syndromes. AMA Arch Dermatol 1957, 75:236-244.
19. Wang L.L., Levy M.L., Lewis R.A., et al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Hum Genet 2001, 102:11-17.
20. Siitonen H.A., Sotkasiira J., Biervliet M., et al. The mutation spectrum in RECQL4 diseases. Eur J Hum Genet 2009, 17:151-158.
21. Siitonen H.A., Kopra O., Kaariainen H., et al. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum Mol Genet 2003, 12(21):2837-2844.
22. Van Maldergem L., Siitonen H.A., Jalkh N., et al. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J Med Genet 2006, 43:148-152.
23. Wang L.L., Gannavarapu A., Kozinetz C.A., et al. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 2003, 95:669-674.
24. Chu W.K., Hickson I.D. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 2009, 9(9):644-654.
25. Ellis N.A., Groden J., Ye T.-Z., et al. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 1995, 83:655-666.
26. Yu C.-E., Oshima J., Fu Y.-H., et al. Positional cloning of the Werner's syndrome gene. Science 1996, 272:258-262.
27. Monnat R.J. Werner syndrome: molecular genetics and mechanistic hypotheses. Exp Gerontol 1992, 27:447-453.
28. Kitao S., Shimamoto A., Goto M., et al. Mutations in RECQ4L cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet 1999, 22:82-84.
29. Kitao S., Ohsugi I., Ichikawa K., et al. Cloning of two new human helicase genes of the RecQ family: biological significance of multiple species in higher eukaryotes. Genomics 1998, 54:443-452.
30. Puranam K.L., Blackshear P.J. Cloning and characterization of RecQL, a potential human homologue of the Escherichia coli DNA helicase RecQ. J Biol Chem 1994, 269:29838-29845.
31. Seki M., Miyazawa H., Tada S., et al. Molecular cloning of cDNA encoding human DNA helicase Q1 which has homology to Escherichia coli RecQ helicase and localization of the gene at chromosome 12p12. Nucleic Acids Res 1994, 22:4566-4573.
32. Sharma S., Stumpo D.J., Balajee A.S., et al. RECQL, a Member of the RecQ Family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol 2007, 27(5):1784-1794.
33. Aygün O., Svejstrup J.Q. RECQL5 helicase: connections to DNA recombination and RNA polymerase II transcription. DNA Repair 2010, 9(3):345-353.
34. Wu Y., Brosh J. Distinct roles of RECQ1 in the maintenance of genomic stability. DNA Repair 2010, 9(3):315-324.
35. German J., Sanz M.M., Ciocci S., Ye T.-Z., Ellis N.A. Syndrome-causing mutations of the BLM gene in persons in the Bloom syndrome registry. Human Mutat 2007, 28:743-753.
36. Moser M.J., Kamath-Loeb A.S., Jacob J.E., et al. WRN helicase expression in Werner syndrome cell lines. Nucleic Acids Res 2000, 28:648-654.
37. Friedrich K., Lee L., Leistritz D., et al. WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. Human Genet 2010, 128(1):103-111.
38. Chen L., Lee L., Kudlow B.A., et al. LMNA mutations in atypical Werner's syndrome. Lancet 2003, 362(9382):440-445.
39. Swanson C., Saintigny Y., Emond M.J., Monnat R.J. The Werner syndrome protein has separable recombination and viability functions. DNA Repair 2004, 3:475-482.
40. Prince P.R., Ogburn C.E., Moser M.J., et al. Cell fusion corrects the 4-nitroquinoline 1-oxide sensitivity of Werner syndrome fibroblast cell lines. Human Genet 1999, 105:132-138.
41. Wang L.L., Worley K., Gannavarapu A., et al. Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome. Am J Hum Genet 2002, 71(1):165-167.
42. Liu Y. Rothmund-Thomson syndrome helicase. RECQL4: on the crossroad between DNA replication and repair. DNA Repair 2010, 9:325-330.
43. Kamath-Loeb A.S., Welcsh P., Waite M., Adman E.T., Loeb L.A. The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C. J Biol Chem 2004, 279(53):55499-55505.
44. Bachrati C.Z., Hickson I.D. RecQ helicases: suppressors of tumorigenesis and premature aging. Biochem J 2003, 374:577-606.
45. Xu X., Liu Y. Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4. EMBO J 2009, 28(5):568-577.
46. Rossi M.L., Ghosh A.K., Bohr V.A. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair 2010, 9(3):331-344.
47. Maizels N. Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 2006, 13(12):1055-1059.
48. Ghosh A., Rossi M.L., Aulds J., Croteau D., Bohr V.A. Telomeric D-loops containing 8-oxo-2′-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1. J Biol Chem 2009, 284(45):31074-31084.
49. Chakraborty P., Grosse F. WRN helicase unwinds Okazaki fragment-like hybrids in a reaction stimulated by the human DHX9 helicase. Nucl Acids Res 2010, 38(14):4722-4730.
50. Huang S., Li B., Gray M.D., et al. The premature aging syndrome protein, WRN, is a 3′ to 5′ exonuclease. Nat Genet 1998, 20:114-116.
51. Shen J.-C., Gray M.D., Oshima J., et al. Werner syndrome protein I: DNA helicase and DNA exonuclease reside on the same polypeptide. J Biol Chem 1998, 273:34139-34144.
52. Kamath-Loeb A.S., Shen J.-C., Loeb L.A., Fry M. Werner syndrome protein II: characterization of the integral 3'→5' DNA exonuclease. J Biol Chem 1998, 273:34145-34150.
53. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007, 8(10):735-748.
54. Wu L., Davies S.L., Levitt N.C., Hickson I.D. Potential role for the BLM helicase in recombinational repair via a conserved interaction with RAD51. J Biol Chem 2001, 276(22):19375-19381.
55. Moynahan M.E., Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010, 11(3):196-207.
56. Kusumoto R., Dawut L., Marchetti C., et al. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing. Biochemistry 2008, 47(28):7548-7556.
57. Harrigan J.A., Wilson D.M., Prasad R., et al. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase β. Nucl Acids Res 2006, 34(2):745-754.
58. Lebel M., Spillare E.A., Harris C.C., Leder P. The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J Biol Chem 1999, 274:37795-37799.
59. Baynton K., Otterlei M., Bjørås M., et al. WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem 2003, 278:36476-36486.
60. Otterlei M., Bruheim P., Ahn B., et al. Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest. J Cell Sci 2006, 119(24):5137-5146.
61. Thangavel S., Mendoza-Maldonado R., Tissino E., et al. The human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol Cell Biol 2009, 30(6):1382-1396.
62. Xu X., Rochette P.J., Feyissa E.A., Su T.V., Liu Y. MCM10 mediates RECQ4 association with MCM2-7 helicase complex during DNA replication. EMBO J 2009, 28(19):3005-3014.
63. Hu Y., Raynard S., Sehorn M.G., et al. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev 2007, 21(23):3073-3084.
64. Schwendener S., Raynard S., Paliwal S., et al. Physical Interaction of RECQ5 helicase with RAD51 facilitates its anti-recombinase activity. J Biol Chem 2010, 285(21):15739-15745.
65. Mao F.J., Sidorova J.M., Lauper J.M., Emond M.J., Monnat R.J. The Human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage. Cancer Res 2010, 70(16):6548-6555.
66. Prince P.R., Emond M.J., Monnat R.J. Loss of Werner syndrome protein function promotes aberrant mitotic recombination. Genes Dev 2001, 15:933-938.
67. Saintigny Y., Makienko K., Swanson C., Emond M.J., Monnat R.J. Homologous recombination resolution defect in Werner syndrome. Mol Cell Biol 2002, 22(20):6971-6978.
68. Bugreev D.V., Mazina O.M., Mazin A.V. Bloom syndrome helicase stimulates RAD51 DNA strand exchange activity through a novel mechanism. J Biol Chem 2009, 284(39):26349-26359.
69. Chu W.K., Hanada K., Kanaar R., Hickson I.D. BLM has early and late functions in homologous recombination repair in mouse embryonic stem cells. Oncogene 2010, 29(33):4705-4714.
70. Nimonkar A.V., Özsoy A.Z., Genschel J., Modrich P., Kowalczykowski S.C. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc Natl Acad Sci U S A 2008, 105(44):16906-16911.
71. Gravel S., Chapman J.R., Magill C., Jackson S.P. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev 2008, 22(20):2767-2772.
72. Wu L. Wrestling off RAD51: a novel role for RecQ helicases. BioEssays 2008, 30(4):291-295.
73. Aggarwal M., Sommers J.A., Morris C., Brosh J. Delineation of WRN helicase function with EXO1 in the replicational stress response. DNA Repair 2010, 9(7):765-776.
74. Wu L., Hickson I.D. The Bloom's syndrome helicase suppresses crossing over during homologous recombination. Nature 2003, 426:870-874.
75. Plank J.L., Wu J., Hsieh Ts. Topoisomerase IIIα and Bloom helicase can resolve a mobile double Holliday junction substrate through convergent branch migration. Proc Natl Acad Sci U S A 2006, 103(30):11118-11123.
76. Wu L., Bachrati C.Z., Ou J., et al. BLAP75/RMI1 promotes the BLM-dependent dissolution of homologous recombination intermediates. Proc Natl Acad Sci U S A 2006, 103(11):4068-4073.
77. Svendsen J.M., Harper J.W. GEN1/Yen1 and the SLX4 complex: solutions to the problem of Holliday junction resolution. Genes Dev 2010, 24(6):521-536.
78. Heyer W.-D., Ehmsen K.T., Liu J. Regulation of homologous recombination in eukaryotes. Annu Rev Genet 2010, 44:113-139.
79. Cheng W.H., von Kobbe C., Opresko P.L., et al. Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J Biol Chem 2004, 279(20):21169-21176.
80. Li B., Navarro S., Kasahara N., Comai L. Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly (ADP-ribose) polymerase-1. J Biol Chem 2004, 279(14):13659-13667.
81. Ahn B., Harrigan J.A., Indig F.E., Wilson D.M., Bohr V.A. Regulation of WRN helicase activity in human base excision repair. J Biol Chem 2004, 279(51):53465-53474.
82. Friedberg E.C., Meira L.B. Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage (Version 6). DNA Repair 2004, 3(12):1617-1638.
83. Sidorova J.M. Roles of the Werner syndrome RecQ helicase in DNA replication. DNA Repair 2008, 7:1776-1786.
84. Rao V.A., Conti C., Guirouilh-Barbat J., et al. Endogenous g-H2AX-ATM-Chk2 checkpoint activation in Bloom's Syndrome helicase-deficient cells is related to DNA replication arrested forks. Mol Cancer Res 2007, 5(7):713-724.
85. Davies S.L., North P.S., Hickson I.D. Role for BLM in replication-fork restart and suppression of origin firing after replicative stress. Nat Struct Mol Biol 2007, 14(7):677-679.
86. Sidorova J.M., Li N., Folch A., Monnat R.J. The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle 2008, 7:796-807.
87. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol Cell 2007, 28:739-745.
88. Warmerdam D.O., Kanaar R. Dealing with DNA damage: relationships between checkpoint and repair pathways. Mut Res/Rev Mut Res 2010, 704(1-3):2-11.
89. Pichierri P., Rosselli F., Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during S-phase of the cell cycle. Oncogene 2003, 22:1491-1500.
90. Davies S.L., North P.S., Dart A., Lakin N.D., Hickson I.D. Phosphorylation of the Bloom's Syndrome helicase and its role in recovery from S-phase arrest. Mol Cell Biol 2004, 24(3):1279-1291.
91. Ouyang K.J., Woo L.L., Zhu J., et al. SUMO modification regulates BLM and RAD51 interaction at damaged replication forks. PLoS Biol 2009, 7(12):e1000252.
92. Cheng W.H., Muftic D., Muftuoglu M., et al. WRN Is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks. Mol Biol Cell 2008, 19(9):3923-3933.
93. Griffith J.D., Comeau L., Rosenfield S., et al. Mammalian telomeres end in a large duplex loop. Cell 1999, 97(4):503-514.
94. O'Sullivan R.J., Karlseder J. Telomeres: protecting chromosomes against genomic instability. Nat Rev Mol Cell Biol 2010, 11:171-181.
95. Opresko P.L. Telomere ResQue and preservation-roles for the Werner syndrome protein and other RecQ helicases. Mech Ageing Dev 2008, 129(1-2):79-90.
96. Crabbe L., Verdun R.E., Haggblom C.I., Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 2004, 306(5703):1951-1953.
97. Crabbe L., Jauch A., Naeger C.M., Holtgreve-Grez H., Karlseder J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci U S A 2007, 104(7):2205-2210.
98. Chang S., Multani A.S., Cabrera N.G., et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004, 36(8):877-882.
99. Du X., Shen J., Kugan N., et al. Telomere shortening exposes functions for the mouse Werner and Bloom Syndrome genes. Mol Cell Biol 2004, 24(19):8437-8446.
100. Artandi S.E., DePinho R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31(1):9-18.
101. Bhattacharyya S., Sandy A., Groden J. Unwinding protein complexes in ALTernative telomere maintenance. J Cell Biochem 2010, 109(1):7-15.
102. Martin G.M., Sprague C.A., Epstein C.J. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest 1970, 23:86-92.
103. Dhillon K.K., Sidorova J., Saintigny Y., et al. Functional role of the Werner syndrome RecQ helicase in human fibroblasts. Aging Cell 2007, 6(1):53-61.
104. Chan K.L., North P.S., Hickson I.D. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J 2007, 26(14):3397-3409.
105. Lahkim Bennani-Belhaj K., Rouzeau S, Buhagiar-Labarchede G., et al. The Bloom syndrome protein limits the lethality associated with RAD51 deficiency. Mol Cancer Res 2010, 8(3):385-394.
106. Hoehn H., Bryant E.M., Au K., et al. Variegated translocation mosaicism in human skin fibroblast cultures. Cytogenet Cell Genet 1975, 15:282-298.
107. Salk D., Au K., Hoehn H., Martin G.M. Cytogenetic aspects of Werner syndrome. Adv Exp Med Biol 1985, 190:541-546.
108. Grant S., Wenger S., Latimer J., Thull D., Burke L. Analysis of genomic instability using multiple assays in a patient with Rothmund-Thomson syndrome. Clin Genet 2000, 58(3):209-215.
109. Maire G., Yoshimoto M., Chilton-MacNeill S., et al. Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma. Neoplasia 2009, 11:260-268.
110. Keller C., Keller K.R., Shew S.B., Plon S.E. Growth deficiency and malnutrition in Bloom syndrome. J Pediatr 1999, 134(4):472-479.
111. Monnat R.J. From broken to old: DNA damage. IGF1 endocrine suppression and aging. DNA Repair 2007, 6(9):1386-1390.
112. Garinis G.A., van der Horst G.T.J., Vijg J., Hoeijmakers H.J. DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 2008, 10(11):1241-1247.
113. Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008, 8(7):512-522.
114. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 2007, 128(1):36-44.
115. Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010, 16(5):238-246.
116. Collado M., Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010, 10(1):51-57.
117. Moser M.J., Bigbee W.L., Grant S.G., et al. Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Res 2000, 60:2492-2496.
118. Ogburn C.E., Oshima J., Poot M., et al. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet 1997, 101:121-125.
119. Schellenberg G.D., Miki T., Yu C.-E., Nakura J. Werner syndrome. The Metabolic & Molecular Basis of Inherited Disease 2001, 785-797. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
120. Agrelo R., Cheng W.H., Setien F., et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A 2006, 103(23):8822-8827.
121. Kawasaki T., Ohnishi M., Suemoto Y., et al. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol 2007, 21:150-158.
122. Aggarwal M., Brosh R.M. Hitting the bull's eye: novel directed cancer therapy through helicase-targeted synthetic lethality. J Cell Biochem 2009, 106:758-763.
123. Gupta R., Brosh R.M. Helicases as prospective targets for anti-cancer therapy. Anticancer Agents Med Chem 2008, 8:390-401.
124. Helleday T. Amplifying tumour-specific replication lesions by DNA repair inhibitors-a new era in targeted cancer therapy. Eur J Cancer 2008, 44(7):921-927.
125. Kaelin W.G. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 2005, 5(9):689-698.
126. Martin S.A., Lord C.J., Ashworth A. DNA repair deficiency as a therapeutic target in cancer. Curr Opin Genet Dev 2008, 18(1):80-86.
127. Helleday T., Petermann E., Lundin C., Hodgson B., Sharma R.A. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 2008, 8(3):193-204.
128. Martin S.A., Hewish M., Lord C.J., Ashworth A. Genomic instability and the selection of treatments for cancer. J Pathol 2010, 220(2):281-289.